You are here: Industry Insights > long-term

News List

Catalent, AveXis Enter Long-term Strategic Mfg. Pact contractpharma
July 17, 2019
AveXis will have dedicated manufacturing space at Paragon’s new commercial manufacturing center near Baltimore-Washington Int’l Airport.
Gap in research means millions living with long-term consequences of cancer worldpharmanews
November 10, 2018
This growing population report side-effects that seriously affect their quality of life, but a combination of a shortage of funding, a lack of clear direction and relatively few researchers with expertise in this area have left a gap in cancer research.
Gap in research means millions living with long-term consequences of cancer worldpharmanews
November 10, 2018
This growing population report side-effects that seriously affect their quality of life, but a combination of a shortage of funding, a lack of clear direction and relatively few researchers with expertise in this area have left a gap in cancer research.
Fasenra Shows Consistent Safety, Efficacy in Long-Term in Severe Eosinophilic Asthma Trial americanpharmaceuticalreview
September 20, 2018
AstraZeneca announced results from the Phase III extension BORA trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as an add-on maintenance treatment in patients with severe eosinophilic asthma who had previously completed one of
Brammer Bio, Sarepta Enter Long-term Mfg. Tie-up contractpharma
June 19, 2018
Sarepta Therapeutics, a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, has entered into a long-term strategic manufacturing partnership with Brammer B
Antidepressant use may contribute to long-term population weight gain worldpharmanews
June 05, 2018
Researchers at King's College London have found that patients prescribed any of the 12 most commonly used antidepressants were 21% more likely to experience an episode of gain weight than those not taking the drugs